- AU$171.72m
- AU$145.79m
- NZ$63.36m
- 47
- 58
- 14
- 36
Annual income statement for Aroa Biosurgery, fiscal year end - March 31st, NZD millions except per share, conversion factor applied.
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 23.3 | 25.1 | 22.3 | 39.7 | 63.4 |
| Cost of Revenue | |||||
| Gross Profit | 16.3 | 18.7 | 15.5 | 30.3 | 53.5 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 22.4 | 27.9 | 40.3 | 47.3 | 66.5 |
| Operating Profit | 0.876 | -2.84 | -18 | -7.64 | -3.11 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -3.05 | -6.16 | -19.1 | -8.26 | -0.384 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 0.96 | -5.96 | -19.2 | -8.39 | -0.396 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 0.96 | -5.96 | -19.2 | -8.39 | -0.396 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 0.96 | -5.96 | -19.2 | -8.39 | -0.396 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.327 | -2.13 | -0.064 | -0.025 | -0.001 |
| Dividends per Share |